This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Virginia C. Weiss, MD; Dennis P. West, MS

Arch Dermatol. 1985;121(2):191-192.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Press reports of preliminary minoxidil research have generated a great deal of public enthusiasm to establish it as a method of treatment for hair loss well before research has been completed and data analyzed for safety and efficacy. It is imperative that we critically assess the status of minoxidil research, the current relevance of minoxidil as a therapeutic modality for hair loss, and the future directions for research in this area.

Minoxidil, a potent direct peripheral vasodilator that is used to control severe hypertension, causes a reversible hypertrichosis in most patients who receive systemic therapeutic doses for one month or longer.^1,2 In 1980, Zappacosta³ reported the reversal of male pattern alopecia in a patient receiving oral minoxidil therapy for hypertension. In 1981, preliminary observations were reported in which two of three patients treated with a 1% topical minoxidil solution had hair regrowth at sites of severe, treatment-resistant alopecia . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?